全文获取类型
收费全文 | 19614篇 |
免费 | 1591篇 |
国内免费 | 713篇 |
专业分类
耳鼻咽喉 | 173篇 |
儿科学 | 317篇 |
妇产科学 | 557篇 |
基础医学 | 2537篇 |
口腔科学 | 410篇 |
临床医学 | 2241篇 |
内科学 | 4096篇 |
皮肤病学 | 237篇 |
神经病学 | 1196篇 |
特种医学 | 472篇 |
外国民族医学 | 3篇 |
外科学 | 2647篇 |
综合类 | 1511篇 |
现状与发展 | 3篇 |
一般理论 | 5篇 |
预防医学 | 1078篇 |
眼科学 | 747篇 |
药学 | 1715篇 |
6篇 | |
中国医学 | 570篇 |
肿瘤学 | 1397篇 |
出版年
2024年 | 35篇 |
2023年 | 225篇 |
2022年 | 460篇 |
2021年 | 691篇 |
2020年 | 455篇 |
2019年 | 493篇 |
2018年 | 572篇 |
2017年 | 506篇 |
2016年 | 497篇 |
2015年 | 667篇 |
2014年 | 808篇 |
2013年 | 927篇 |
2012年 | 1389篇 |
2011年 | 1492篇 |
2010年 | 888篇 |
2009年 | 723篇 |
2008年 | 1090篇 |
2007年 | 1192篇 |
2006年 | 1146篇 |
2005年 | 1131篇 |
2004年 | 921篇 |
2003年 | 787篇 |
2002年 | 776篇 |
2001年 | 548篇 |
2000年 | 547篇 |
1999年 | 488篇 |
1998年 | 201篇 |
1997年 | 211篇 |
1996年 | 176篇 |
1995年 | 124篇 |
1994年 | 118篇 |
1993年 | 85篇 |
1992年 | 211篇 |
1991年 | 201篇 |
1990年 | 186篇 |
1989年 | 162篇 |
1988年 | 133篇 |
1987年 | 112篇 |
1986年 | 91篇 |
1985年 | 63篇 |
1984年 | 43篇 |
1983年 | 32篇 |
1982年 | 46篇 |
1981年 | 39篇 |
1980年 | 35篇 |
1979年 | 36篇 |
1978年 | 32篇 |
1977年 | 19篇 |
1975年 | 20篇 |
1973年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
121.
F. W. S. Ko H. Y. Wang† G. W. K. Wong‡ T. F. Leung‡ D. S. C. Hui D. P. S. Chan N. S. Zhong† C. K.W. Lai 《Clinical and experimental allergy》2005,35(11):1449-1456
BACKGROUND: Asthma is a common chronic disease and information on its management practices at the community level is helpful in identifying problems and improving asthma care. OBJECTIVE: To assess the severity status and management of the asthma symptom of wheeze of children at the community level in Hong Kong (HK) and Guangzhou (GZ). METHODS: Cross-sectional study of children aged 10 years using the International Study of Asthma and Allergic disease in Childhood (ISAAC Phase II protocol). Asthma management and lung function were assessed in 178 (98 from HK and 80 from GZ) randomly selected children with wheeze over the past 12 months. RESULTS: Eighty-three percent, 11%, 6% and 0% of children suffered from intermittent, mild persistent, moderate persistent and severe persistent asthma, respectively, according to the frequency of their symptoms. Addition of spirometric parameter only changed the asthma severity classification in 2.8% of children. Medications were used by 30.6% and 71.3% of children for wheeze in HK and GZ, respectively. In HK, inhaled beta(2)-agonist (73.3% among the drug users) was the commonest medication used followed by inhaled corticosteroid (ICS) (23.3%). In GZ, inhaled beta(2)-agonist was used by 75.4% of children, but use of ICS (26.3%), oral beta(2)-agonist (26.3%), oral theophylline (45.6%), oral ketotifen (36.8%) and oral steroid (35.1%) were also common. ICS was only used by 11.4% of children with persistent asthma. Ten percent and 18.7% of children in HK and GZ, respectively, had emergency department visits, while 16.3% and 11.6% of children in HK and GZ, respectively, had missed school secondary to asthma over the past 1 year. CONCLUSIONS: Most children in the community had intermittent asthma and addition of lung function to symptoms did not significantly affect classification of asthma severity. Significant morbidity was seen even in this group of children with mostly intermittent and mild persistent asthma. 相似文献
122.
Alessia Lai Annalisa Bergna Carla Acciarri Massimo Galli Gianguglielmo Zehender 《Journal of medical virology》2020,92(6):675-679
To reconstruct the evolutionary dynamics of the 2019 novel-coronavirus recently causing an outbreak in Wuhan, China, 52 SARS-CoV-2 genomes available on 4 February 2020 at Global Initiative on Sharing All Influenza Data were analyzed. The two models used to estimate the reproduction number (coalescent-based exponential growth and a birth-death skyline method) indicated an estimated mean evolutionary rate of 7.8 × 10−4 subs/site/year (range, 1.1 × 10−4-15 × 10−4) and a mean tMRCA of the tree root of 73 days. The estimated R value was 2.6 (range, 2.1-5.1), and increased from 0.8 to 2.4 in December 2019. The estimated mean doubling time of the epidemic was between 3.6 and 4.1 days. This study proves the usefulness of phylogeny in supporting the surveillance of emerging new infections even as the epidemic is growing. 相似文献
123.
Lai AC Chambers TM Holland RE Morley PS Haines DM Townsend HG Barrandeguy M 《Archives of virology》2001,146(6):1063-1074
Summary. We reported previously that equine-2 influenza A virus (H3N8) had evolved into two genetically and antigenically distinct
“Eurasian” and “American” lineages. Phylogenetic analysis, using the HA1 gene of more recent American isolates, indicated
a further divergence of these viruses into three evolution lineages: A South American lineage, a Kentucky lineage, and a Florida
lineage. These multiple evolution pathways were not due to geographic barriers, as viruses from different lineages co-circulated.
For the Kentucky lineage, the evolution rate was estimated to be 0.89 amino acid substitutions per year, which agreed with
the previously estimated rate of 0.8. For the South American lineage, the evolution rate was estimated to be only 0.27 amino
acid substitutions per year. This low evolution rate was probably due to a unique alternating Ser138 to Ala138 substitutions
at antigenic site A. For the Kentucky lineage, there was a preference for sequential nonsynonymous substitutions at antigenic
site B, which was also a “hot spot” for amino acid substitutions. Convalescent sera had minimal cross-reactivity to viruses
of different lineages, indicating antigenic distinctions among these viruses. In contrast to human H3N2 viruses, our results
suggested that the evolution of equine-2 influenza virus resembled the multiple evolution pathways of influenza B virus.
Accepted December 14, 2000 Received September 19, 2000 相似文献
124.
Ewanowich C Brynes RK Medeiros L McCourty A Lai R 《Archives of pathology & laboratory medicine》2001,125(2):208-210
OBJECTIVE: We previously surveyed cyclin D1 expression in common acquired nevi, Spitz nevi, and malignant melanomas and reported that benign nevi maintain a zonal pattern of cyclin D1 expression, in contrast with malignant melanomas. Our aim was to extend those observations by examining cyclin D1 expression in dysplastic nevi. METHODS: Cyclin D1 overexpression in 23 dysplastic nevi was detected by an immunohistochemical technique. The extent of atypia of the nevi was graded as mild, moderate, or severe, using previously established criteria. RESULTS: Cyclin D1 overexpression in dysplastic nevi maintained a zonal pattern, similar to Spitz nevi. Cyclin D1 overexpression was greatest in the region of the epidermal-dermal junction and was significantly less prominent in the papillary and reticular dermis, suggesting that cyclin D1 expression is under cell control and correlates with maturation of nevus cells. Cyclin D1 overexpression also correlated with cytologic atypia, as dysplastic nevi with moderate or severe cytologic atypia contained a greater percentage of cyclin D1-positive cells than did nevi with mild atypia. Six dysplastic nevi with many cyclin D1--positive cells were assessed by fluorescence in situ hybridization studies using cyclin D1--specific and chromosome 11 centromeric probes. In all cases, there was no evidence of 11q13 translocation, amplification, or trisomy of chromosome 11. CONCLUSIONS: Cyclin D1 may be involved in the pathogenesis of dysplastic nevi. Cyclin D1 overexpression does not appear to be explained by cyclin D1 locus amplification or translocation in most cases, and it may be a result of other cell abnormalities that up-regulate the protein level of cyclin D1. 相似文献
125.
目的:研制抗血小板膜糖蛋白Ⅱb/Ⅲa Fab抗体。方法:通过问接免疫荧光试验和血小板聚集抑制试验,选取鼠源抗血小板糖蛋白Ⅱb/Ⅲa单克隆抗体(mAb P140)。从分泌该mAb的杂交瘤细胞株(P140)中,克隆到抗体轻链基因和重链Fd段基因,构建原核表达重组质粒p3MH/P140x-Fd,并在XLI-Blu菌株中进行表达。采用钴亲和层析法对P140 Fab抗体进行纯化,用SDS-PAGE、ELISA和Western blot等方法,对P140 Fab抗体进行检测,并通过血小板聚集抑制试验,观察P140 Fab抗体的抗栓活性。结果:SDS-PAGE和Western blot表明,纯化的P140Fab抗体的相对分子质量(Mr)约为47000。ELISA的结果显示,P140 Fab抗体可与人血小板特异性结合。在体外ADP诱导的血小板聚集试验中,P140 Fab抗体对血小板聚集的抑制作用成剂量依赖性,IC50的平均值为16.85mg/L。结论:成功地研制出具有抗栓活性的抗血小板膜糖蛋白Ⅱb/Ⅲa的Fab抗体。 相似文献
126.
Invasive pulmonary aspergillosis: high incidence of disseminated intravascular coagulation in fatal cases. 总被引:2,自引:0,他引:2
Chih Cheng Lai Shwu Jen Liaw Li Na Lee Cheng Hsiang Hsiao Chong Jen Yu Po Ren Hsueh 《Journal of microbiology, immunology, and infection》2007,40(2):141-147
BACKGROUND AND PURPOSE: Disseminated intravascular coagulation (DIC) is a rarely described finding in invasive pulmonary aspergillosis (IPA) with unclear impact on mortality. METHODS: This study included patients with positive cultures of Aspergillus spp. from respiratory specimens, serological evidence of aspergillosis, or lung biopsy findings supporting aspergillosis treated at National Taiwan University Hospital from January 1999 to June 2005. IPA was defined based on the consensus of the European Organization for Research and Treatment of Cancer, and the Mycosis Study Group of the National Institute of Allergy and Infectious Diseases. Univariate logistic regression analysis was used to evaluate the factors associated with mortality. RESULTS: Proven or probable IPA was diagnosed in 26 patients. Hematological malignancy was found in 11 patients (42%) and immunosuppressive agents had been administered to 17 patients (65%). Among 20 culture-proven infections (77%), the most frequently encountered fungi were Aspergillus fumigatus (46%) and Aspergillus flavus (23%). The overall mortality rate was 62%. Univariate and multivariate analyses revealed that DIC was the only factor that was significantly associated with death attributable to IPA (p<0.01). CONCLUSIONS: IPA is associated with a high mortality rate, particularly for patients with DIC. 相似文献
127.
Heterogeneity of hepatitis delta antigen 总被引:10,自引:0,他引:10
Hepatitis delta antigen (HDAg) is the only known protein encoded by the hepatitis delta virus (HDV). Two HDAg species of different sizes have been detected in the sera and livers of the infected humans, chimpanzees, and woodchucks, even though only one RNA species was previously identified in most of the HDV strains. To study HDAg heterogeneity, we took advantage of the fact that a single base mutation at nucleotide 1015 (C to U), which results in an amber termination codon in the HDAg open reading frame (ORF), eliminates a unique Ncol restriction enzyme site. We screened various HDV cDNA clones and detected sequence heterogeneity of the HDAg-coding region on the basis of the presence or absence of the Ncol site. Five delta hepatitis patients were examined. In every patient, two types of HDAg-coding sequence were detected at nucleotide 1015: one which contains a C and results in an ORF encoding a delta antigen of 214 amino acids, and the other which possesses a U and results in an amber termination codon and a truncated HDAg species of 195 amino acids. The in vitro translation products of these two ORFs comigrated with the two HDAg species from the patient's plasma on SDS polyacrylamide gels. Polymerase chain reaction (PCR) amplification of the HDV RNA from some patients' sera and subsequent sequencing showed several additional mutations in the HDAg-coding region. These mutations are independent of the C or U nucleotide change at the site of the amber termination codon.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
128.
Qing Lei Yang Li Hong-yan Hou Feng Wang Zhu-qing Ouyang Yandi Zhang Dan-yun Lai Jo-Lewis Banga Ndzouboukou Zhao-wei Xu Bo Zhang Hong Chen Jun-biao Xue Xiao-song Lin Yun-xiao Zheng Zong-jie Yao Xue-ning Wang Cai-zheng Yu He-wei Jiang Hai-nan Zhang Huan Qi Shu-juan Guo Sheng-hai Huang Zi-yong Sun Sheng-ce Tao Xiong-lin Fan 《Allergy》2021,76(2):551-561
Background
The missing asymptomatic COVID-19 infections have been overlooked because of the imperfect sensitivity of the nucleic acid testing (NAT). Globally understanding the humoral immunity in asymptomatic carriers will provide scientific knowledge for developing serological tests, improving early identification, and implementing more rational control strategies against the pandemic.Measure
Utilizing both NAT and commercial kits for serum IgM and IgG antibodies, we extensively screened 11 766 epidemiologically suspected individuals on enrollment and 63 asymptomatic individuals were detected and recruited. Sixty-three healthy individuals and 51 mild patients without any preexisting conditions were set as controls. Serum IgM and IgG profiles were further probed using a SARS-CoV-2 proteome microarray, and neutralizing antibody was detected by a pseudotyped virus neutralization assay system. The dynamics of antibodies were analyzed with exposure time or symptoms onset.Results
A combination test of NAT and serological testing for IgM antibody discovered 55.5% of the total of 63 asymptomatic infections, which significantly raises the detection sensitivity when compared with the NAT alone (19%). Serum proteome microarray analysis demonstrated that asymptomatics mainly produced IgM and IgG antibodies against S1 and N proteins out of 20 proteins of SARS-CoV-2. Different from strong and persistent N-specific antibodies, S1-specific IgM responses, which evolved in asymptomatic individuals as early as the seventh day after exposure, peaked on days from 17 days to 25 days, and then disappeared in two months, might be used as an early diagnostic biomarker. 11.8% (6/51) mild patients and 38.1% (24/63) asymptomatic individuals did not produce neutralizing antibody. In particular, neutralizing antibody in asymptomatics gradually vanished in two months.Conclusion
Our findings might have important implications for the definition of asymptomatic COVID-19 infections, diagnosis, serological survey, public health, and immunization strategies.129.
Chia-Ying Liu Chih-Cheng Lai Hsiu-Tzy Chiang Min-Chi Lu Ling-Fang Wang Tsai-Ling Tsai Mei-Yu Kang Yi-Ni Jan Yi-Ting Lo Wen-Chien Ko Shu-Hui Tseng Chun-Ming Lee Po-Ren Hsueh 《Journal of microbiology, immunology, and infection》2019,52(1):62-74
Background/purpose
This study investigated the distribution and persistence of multidrug resistant organisms (MDROs) including methicillin-resistant Staphylococcus aureus (MRSA), carbapenem-resistant Enterobacteriaceae (CRE), carbapenem-resistant Pseudomonas aeruginosa (CRPA), and multidrug-resistant Acinetobacter baumannii (MDRAB) in six long-term care facilities (LTCFs).Methods
We investigated the distribution of MDROs in residents of six LTCFs and their environments from January to December 2016 (intervention period). Active surveillance of colonization of MDROs was performed by culturing rectal and nasal swab samples from the residents every three months. Multilocus sequence typing (MLST) was conducted, and genes for panton-valentine leukocidin (PVL) from MRSA isolates were determined.Results
A total of 521 samples were positive for MDROs, and MRSA was the most common organism (65.1%), followed by MDRAB (11.3%), carbapenem-resistant Klebsiella pneumoniae (11.1%), carbapenem-resistant Escherichia coli (4.6%), and carbapenem-resistant P. aeruginosa (2.1%, n = 11). By a linear regression model, positive MRSA isolates from the environment were found to be statistically significant and associated with the number of colonized LTCF residents (p = 0.01), while the timing of the surveillance culture was not (p = 0.227). The main MLST types associated with PVL-production were sequence type (ST) 59, (40.0%, 24/60), ST30 (21.4%, 3/14), ST8 (87.5%, 14/16), and ST45 (3.6%, 1/28). The susceptibility rates of tetracycline (96.7%), trimethoprim-sulfamethoxazole (96.7%), and ciprofloxacin (81.7%) were statistically significant and higher in MRSA ST59, compared to the rates in MRSA ST45 isolates.Conclusions
MRSA was the most commonly colonized MDRO, both in the LTCF residents and in the environment, followed by MDRAB and carbapenem-resistant K. pneumoniae. 相似文献130.
Contribution of histamine and prostanoids to bronchoconstriction provoked by inhaled bradykinin in atopic asthma 总被引:6,自引:1,他引:6
Bradykinin, a nonapeptide cleavage product of high molecular weight kininogen, is a potent bronchoconstrictor agonist in asthma; however, its mechanism of action is not known. Since bradykinin has been shown to stimulate mediator release from mast cells and augment the release of prostanoids, we have examined the effect of a selective histamine H1 receptor antagonist, terfenadine and a potent cyclooxygenase inhibitor, flurbiprofen on bronchoconstriction provoked by inhaled bradykinin in asthma. As a bronchial provocation procedure bradykinin challenge was repeatable to within 1 doubling dilution. In nine atopic asthmatic subjects, terfenadine 180 mg, when compared to placebo, increased the geometric mean provocation concentration of inhaled agonist required to reduce FEV1 by 20% of baseline (PC20) from 0.7 to greater than 22.9 mg/ml for histamine (P less than 0.01) and 0.3 to 0.5 mg/ml for bradykinin (P less than 0.01). In a further nine atopic asthmatics, flurbiprofen 150 mg when compared to placebo produced a small but significant protection of the airways against bradykinin, geometric mean PC20 increasing from 0.40 to 0.79 mg/ml (P less than 0.05). We conclude that bradykinin is a potent bronchoconstrictor agonist in asthma, being approximately 9.5 times more potent than histamine in molar terms. Pharmacological intervention with terfenadine and flurbiprofen led to a significant protection of the airways against the constrictor effect of bradykinin but the effect in each case was small. Thus, while histamine and prostanoids may contribute as mediators of bradykinin-induced bronchoconstriction, they are unlikely to account for the majority of the response. 相似文献